JPWO2020115257A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2020115257A5
JPWO2020115257A5 JP2021532415A JP2021532415A JPWO2020115257A5 JP WO2020115257 A5 JPWO2020115257 A5 JP WO2020115257A5 JP 2021532415 A JP2021532415 A JP 2021532415A JP 2021532415 A JP2021532415 A JP 2021532415A JP WO2020115257 A5 JPWO2020115257 A5 JP WO2020115257A5
Authority
JP
Japan
Prior art keywords
coating
core
copolymer
enteric
formulation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021532415A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022515340A (ja
JP7423629B2 (ja
Publication date
Priority claimed from EP18211141.9A external-priority patent/EP3662900A1/en
Application filed filed Critical
Publication of JP2022515340A publication Critical patent/JP2022515340A/ja
Publication of JPWO2020115257A5 publication Critical patent/JPWO2020115257A5/ja
Application granted granted Critical
Publication of JP7423629B2 publication Critical patent/JP7423629B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021532415A 2018-12-07 2019-12-05 結腸ドラッグデリバリー製剤 Active JP7423629B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP18211141.9 2018-12-07
EP18211141.9A EP3662900A1 (en) 2018-12-07 2018-12-07 Colonic drug delivery formulation
PCT/EP2019/083912 WO2020115257A1 (en) 2018-12-07 2019-12-05 Colonic drug delivery formulation

Publications (3)

Publication Number Publication Date
JP2022515340A JP2022515340A (ja) 2022-02-18
JPWO2020115257A5 true JPWO2020115257A5 (pt) 2023-10-06
JP7423629B2 JP7423629B2 (ja) 2024-01-29

Family

ID=64661226

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021532415A Active JP7423629B2 (ja) 2018-12-07 2019-12-05 結腸ドラッグデリバリー製剤

Country Status (13)

Country Link
US (1) US20220016037A1 (pt)
EP (2) EP3662900A1 (pt)
JP (1) JP7423629B2 (pt)
KR (1) KR20210100666A (pt)
CN (1) CN113164400A (pt)
AR (1) AR117281A1 (pt)
AU (1) AU2019394740A1 (pt)
BR (1) BR112021010913A2 (pt)
CA (1) CA3122033A1 (pt)
EA (1) EA202191431A1 (pt)
IL (1) IL283719A (pt)
MA (1) MA54376A (pt)
WO (1) WO2020115257A1 (pt)

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8812490D0 (en) 1988-05-26 1988-06-29 Agricultural & Food Res Delayed release formulations
GB8926639D0 (en) 1989-11-24 1990-01-17 Agricultural & Food Res Delayed release formulations
US5422121A (en) 1990-11-14 1995-06-06 Rohm Gmbh Oral dosage unit form
US5656290A (en) 1993-02-26 1997-08-12 The Procter & Gamble Company Bisacodyl dosage form with multiple enteric polymer coatings for colonic delivery
GB9722426D0 (en) 1997-10-23 1997-12-24 Univ London Pharmacy Controlled release formulations
GB9724186D0 (en) 1997-11-14 1998-01-14 British Tech Group Low temperature coatings
FI20000780A (fi) 2000-04-03 2001-10-04 Novasso Oy Peroraalinen lääkemuoto lääkeaineen hallituksi vapauttamiseksi
GB2367002A (en) 2000-09-25 2002-03-27 British Sugar Plc Coating composition
GB0203421D0 (en) 2002-02-13 2002-04-03 Alizyme Therapeutics Ltd Composition
US7670627B2 (en) 2002-12-09 2010-03-02 Salvona Ip Llc pH triggered targeted controlled release systems for the delivery of pharmaceutical active ingredients
DE102005032806A1 (de) 2005-07-12 2007-01-18 Röhm Gmbh Verwendung eines teilneutralisierten, anionischen (Meth)acrylat-Copolymers als Überzug für die Herstellung einer Arzneiform mit einer Wirkstofffreisetzung bei erniedrigten pH-Werten
GB0607534D0 (en) 2006-04-13 2006-05-24 Univ London Pharmacy Colonic drug delivery formulation
ES2759626T3 (es) 2007-05-07 2020-05-11 Evonik Operations Gmbh Formas farmacéuticas sólidas que comprenden un recubrimiento entérico con liberación acelerada del fármaco
EP4011364B1 (en) * 2011-03-23 2023-12-13 Ironshore Pharmaceuticals & Development, Inc. Methods and compositions for treatment of attention deficit disorder
CU24342B1 (es) * 2012-04-30 2018-05-08 Tillotts Pharma Ag Formulación de fármaco de liberación retardada
HUE036187T2 (hu) 2012-04-30 2018-06-28 Tillotts Pharma Ag Késleltetett leadású gyógyszerkészítmény
UA117260C2 (uk) * 2013-10-29 2018-07-10 Тиллоттс Фарма АГ Лікарський препарат з відстроченим вивільненням
EP3413877B1 (en) * 2016-02-09 2021-04-07 Albireo AB Oral cholestyramine formulation and use thereof

Similar Documents

Publication Publication Date Title
JP5176017B2 (ja) 結腸薬物送達製剤
JP6621662B2 (ja) 遅延放出性薬物製剤
JP2020063290A (ja) 放出調節コーティングカプセル
JP2020063295A (ja) 放出調節コーティングカプセル
CA2679409A1 (fr) Film monocouche a desintegration rapide pour l'administration buccale de substances actives
JP6700220B2 (ja) 遅延放出性薬物製剤
JPWO2020115257A5 (pt)
US5356634A (en) Controlled-release delivery system
TWI827753B (zh) 結腸藥物遞送配方
CN1232386A (zh) 弱酸药物的结肠运送
TWI837237B (zh) 結腸藥物遞送配方
JP7423629B2 (ja) 結腸ドラッグデリバリー製剤
JPWO2020115254A5 (pt)
WO2021094697A1 (fr) Procédé de fabrication d'une composition pharmaceutique à administration orale et à délivrance colonique
JPWO2020115255A5 (pt)
WO2003030874A1 (fr) Composition pharmaceutique destinee a liberer une substance active au niveau du colon
TW202033201A (zh) 製造無還原糖5-asa錠劑核心的方法
Kumar et al. Polysaccharides Based Colon Specific Drug delivery: A